These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21926276)

  • 41. Protective effects of allicin on streptozotocin-induced diabetic nephropathy in rats.
    Huang H; Jiang Y; Mao G; Yuan F; Zheng H; Ruan Y; Wu T
    J Sci Food Agric; 2017 Mar; 97(4):1359-1366. PubMed ID: 27363537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
    Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
    Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined inhibition of CCR2 and ACE provides added protection against progression of diabetic nephropathy in
    Tesch GH; Pullen N; Jesson MI; Schlerman FJ; Nikolic-Paterson DJ
    Am J Physiol Renal Physiol; 2019 Dec; 317(6):F1439-F1449. PubMed ID: 31566438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouse.
    Jha JC; Dai A; Holterman CE; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm KAM
    Diabetologia; 2019 Sep; 62(9):1712-1726. PubMed ID: 31222503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diabetic kidney disease in FVB/NJ Akita mice: temporal pattern of kidney injury and urinary nephrin excretion.
    Chang JH; Paik SY; Mao L; Eisner W; Flannery PJ; Wang L; Tang Y; Mattocks N; Hadjadj S; Goujon JM; Ruiz P; Gurley SB; Spurney RF
    PLoS One; 2012; 7(4):e33942. PubMed ID: 22496773
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deletion of p47phox attenuates the progression of diabetic nephropathy and reduces the severity of diabetes in the Akita mouse.
    Liu GC; Fang F; Zhou J; Koulajian K; Yang S; Lam L; Reich HN; John R; Herzenberg AM; Giacca A; Oudit GY; Scholey JW
    Diabetologia; 2012 Sep; 55(9):2522-32. PubMed ID: 22653270
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blockade of CCL2/CCR2 signalling ameliorates diabetic nephropathy in db/db mice.
    Seok SJ; Lee ES; Kim GT; Hyun M; Lee JH; Chen S; Choi R; Kim HM; Lee EY; Chung CH
    Nephrol Dial Transplant; 2013 Jul; 28(7):1700-10. PubMed ID: 23794669
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of the epidermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy.
    Advani A; Wiggins KJ; Cox AJ; Zhang Y; Gilbert RE; Kelly DJ
    Nephrology (Carlton); 2011 Aug; 16(6):573-81. PubMed ID: 21342330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Loss of TIMP3 selectively exacerbates diabetic nephropathy.
    Basu R; Lee J; Wang Z; Patel VB; Fan D; Das SK; Liu GC; John R; Scholey JW; Oudit GY; Kassiri Z
    Am J Physiol Renal Physiol; 2012 Nov; 303(9):F1341-52. PubMed ID: 22896043
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phlorizin pretreatment reduces acute renal toxicity in a mouse model for diabetic nephropathy.
    Brouwers B; Pruniau VPEG; Cauwelier EJG; Schuit F; Lerut E; Ectors N; Declercq J; Creemers JWM
    J Biol Chem; 2013 Sep; 288(38):27200-27207. PubMed ID: 23940028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-diabetic and renoprotective effects of aliskiren in streptozotocin-induced diabetic nephropathy in female rats.
    Mahfoz AM; El-Latif HA; Ahmed LA; Hassanein NM; Shoka AA
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1315-1324. PubMed ID: 27612855
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Akita spontaneously type 1 diabetic mice exhibit elevated vascular arginase and impaired vascular endothelial and nitrergic function.
    Toque HA; Nunes KP; Yao L; Xu Z; Kondrikov D; Su Y; Webb RC; Caldwell RB; Caldwell RW
    PLoS One; 2013; 8(8):e72277. PubMed ID: 23977269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Delayed Treatment with a Small Pigment Epithelium Derived Factor (PEDF) Peptide Prevents the Progression of Diabetic Renal Injury.
    Awad AS; You H; Gao T; Gvritishvili A; Cooper TK; Tombran-Tink J
    PLoS One; 2015; 10(7):e0133777. PubMed ID: 26207369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury.
    Wong DW; Oudit GY; Reich H; Kassiri Z; Zhou J; Liu QC; Backx PH; Penninger JM; Herzenberg AM; Scholey JW
    Am J Pathol; 2007 Aug; 171(2):438-51. PubMed ID: 17600118
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High Elmo1 expression aggravates and low Elmo1 expression prevents diabetic nephropathy.
    Hathaway CK; Chang AS; Grant R; Kim HS; Madden VJ; Bagnell CR; Jennette JC; Smithies O; Kakoki M
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2218-22. PubMed ID: 26858454
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats.
    Manigrasso MB; Sawyer RT; Hutchens ZM; Flynn ER; Maric-Bilkan C
    Am J Physiol Renal Physiol; 2012 May; 302(9):F1203-9. PubMed ID: 22301628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knockout of Na
    Song P; Huang W; Onishi A; Patel R; Kim YC; van Ginkel C; Fu Y; Freeman B; Koepsell H; Thomson S; Liu R; Vallon V
    Am J Physiol Renal Physiol; 2019 Jul; 317(1):F207-F217. PubMed ID: 31091127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury.
    Aroor AR; Das NA; Carpenter AJ; Habibi J; Jia G; Ramirez-Perez FI; Martinez-Lemus L; Manrique-Acevedo CM; Hayden MR; Duta C; Nistala R; Mayoux E; Padilla J; Chandrasekar B; DeMarco VG
    Cardiovasc Diabetol; 2018 Jul; 17(1):108. PubMed ID: 30060748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Macrophages directly mediate diabetic renal injury.
    You H; Gao T; Cooper TK; Brian Reeves W; Awad AS
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1719-27. PubMed ID: 24173355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.